Search

everythinglearnresearchcommunity

for

Search:↓

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

Liquid nitrogen cryotherapy and betamethasone lotion are equally effective for treating alopecia areata.

Tailored treatment plans are crucial for managing canine dermatomyositis-like disease.

Pure carbon nanotubes are safe for mice, but impure ones cause immune issues and hair loss.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

EPDS and MS might share an immune-related cause.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

A fungal infection can look like a different scalp condition in teens, leading to wrong treatment until proper tests are done.

CCCA may be caused by both hair traction and an immune response.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Hair loss may be an early sign of serious illnesses like Hodgkin disease.

A man developed a rare scalp disorder, Folliculitis Decalvans, 20 years after hair restoration surgery, and it required long-term antibiotic treatment.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Dermal stem cells help regenerate hair follicles and heal skin wounds.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

New effective scar treatments are urgently needed due to the current options' limited success.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Hidradenitis suppurativa treatment should be tailored to the individual, with quitting smoking being important.

Epidermal stem cells could lead to new treatments for skin and hair disorders.

Recognizing oral symptoms can help diagnose and treat blood and nutritional diseases early.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Personalized treatment plans improve vitiligo care.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.